28 related articles for article (PubMed ID: 3399656)
1. Studies on radiopharmaceuticals. Synthesis of a new renal scanning agent and basic studies.
Tanaka A; Tojyo K; Urakubo G; Miki M; Machida T
Nucl Med (Stuttg); 1972 Dec; 11(4):407-18. PubMed ID: 4652122
[No Abstract] [Full Text] [Related]
2. Rapid radiochemical purity testing for [131I]m-iodobenzylguanidine.
Hung JC; Wilson ME
Nucl Med Biol; 1995 Feb; 22(2):227-9. PubMed ID: 7767317
[TBL] [Abstract][Full Text] [Related]
3. [Medullary cancer of the thyroid in type IIB multiple endocrine neoplasia. Uptake of meta-iodo-benzylguanidine labeled with iodine 131].
Chamouard P; Jouin H; Varra A; Weill JP; Constantinesco A
Presse Med; 1985 Jun; 14(25):1387. PubMed ID: 2862629
[No Abstract] [Full Text] [Related]
4. Synthesis and biological activities of substance P iodinated derivatives.
Michelot R; Gozlan H; Beaujouan JC; Besson MJ; Torrens Y; Glowinski J
Biochem Biophys Res Commun; 1980 Jul; 95(2):491-8. PubMed ID: 6158320
[No Abstract] [Full Text] [Related]
5. Iodophenylsulfonamide fatty acid analogs as potential myocardial imaging agents.
Fritzberg AR; Eshima D
Int J Appl Radiat Isot; 1982 Jun; 33(6):451-3. PubMed ID: 7107040
[No Abstract] [Full Text] [Related]
6. Radioiodine-labeled N,N-dimethyl-N'-(2-hydroxy-3-alkyl-5-iodobenzyl)-1,3-propanediamines for brain perfusion imaging.
Tramposch KM; Kung HF; Blau M
J Med Chem; 1983 Feb; 26(2):121-5. PubMed ID: 6402595
[No Abstract] [Full Text] [Related]
7. Synthesis of 15-(p-iodophenyl) pentadecanoic acid labelled with carbon-14.
Le Bars D; Luu-Duc C; Leo PM; Apparu M; Vidal M; Comet M
Int J Rad Appl Instrum A; 1986; 37(3):256-7. PubMed ID: 3019938
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, radiolabelling and stability of radioiodinated m-iodobenzylguanidine, a review.
Wafelman AR; Konings MC; Hoefnagel CA; Maes RA; Beijnen JH
Appl Radiat Isot; 1994 Oct; 45(10):997-107. PubMed ID: 7994289
[TBL] [Abstract][Full Text] [Related]
9. Renal failure as a cause of false-positive on metaiodobenzilguanidine (MIBG) scan.
Gallar P; Oliet A; Hernandez E; Vigil A; Ortega O
Nephrol Dial Transplant; 1993; 8(5):481. PubMed ID: 8393560
[No Abstract] [Full Text] [Related]
10. [131-I-MIBG--pharmacokinetics and dosimetry].
Blottner A; Bratouss A; Ertl S; Wollny P
Radiobiol Radiother (Berl); 1988; 29(2):202-5. PubMed ID: 3399657
[No Abstract] [Full Text] [Related]
11. No-carrier-added meta-[123I]iodobenzylguanidine: synthesis and preliminary evaluation.
Vaidyanathan G; Zalutsky MR
Nucl Med Biol; 1995 Jan; 22(1):61-4. PubMed ID: 7735171
[TBL] [Abstract][Full Text] [Related]
12. Routine production and quality control of 123I-labelled mIBG at NAC.
Rossouw DD
Int J Rad Appl Instrum A; 1992 Oct; 43(10):1301-2. PubMed ID: 1330981
[No Abstract] [Full Text] [Related]
13. [Synthesis and characterization of m-I-benzylguanidine].
Bratouss A
Radiobiol Radiother (Berl); 1988; 29(2):199-202. PubMed ID: 3399656
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]